OUTCOMES OF SSc ASSOCIATED POLYARTHRITIS OR MYOSITIS IN PATIENTS TREATED BY BIOTHERAPIES TOCILIZUMAB OR ABATACEPT: A EUSTAR OBSERVATIONAL STUDY

被引：0
|
作者：
Meunier, M. [1 ]
Matucci, M. [2 ]
Maurer, B. [3 ]
Riemekasten, G. [4 ]
Pellerito, R. [5 ]
Von Mulhen, C. A. [6 ]
Vacca, V. [7 ]
Airo, P. [8 ]
Bartoli, F. [2 ]
Fiori, G. [2 ]
Bokarewa, M. [9 ]
Disler, O. [3 ]
Allanore, Y. [1 ]
机构：
[1] Paris Descartes Univ, Rheumatol Dept A, Paris, France
[2] Rheumatol Sect, Dept Biomed, Florence, Italy
[3] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[4] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
[5] Ordine Mauriziano Hosp, Div Rheumatol, Turin, Italy
[6] Pontificia Univ Catolica Rio Grande do Sul, St Lucas Hosp, Dept Rheumatol, Porto Alegre, Brazil
[7] Dept Med Sci, Chair Rheumatol 2, Cagliari, Italy
[8] Rheumatol & Clin Immunol Serv, Brescia, Italy
[9] Inst Med, Gothenburg, Sweden
来源：
RHEUMATOLOGY | 2012年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Outcomes of Systemic Sclerosis Associated Polyarthritis Patients Treated by Biotherapies Tocilizumab or Abatacept: A EUSTAR Observational Study
    Meunier, Marine
    Cerinic, Marco Matucci
    Maurer, Britta
    Riemekasten, Gabriela
    Pellerito, Raffaele
    von Muehlen, Carlos Alberto
    Vacca, Alessandra
    Airo, Paolo
    Bartoli, Francesca
    Fiori, Ginevra
    Distler, Oliver
    Allanore, Yannick
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S572 - S572
  • [2] Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
    Elhai, Muriel
    Meunier, Marine
    Matucci-Cerinic, Marco
    Maurer, Britta
    Riemekasten, Gabriela
    Leturcq, Tifenn
    Pellerito, Raffaele
    Von Muehlen, Carlos Alberto
    Vacca, Alessandra
    Airo, Paolo
    Bartoli, Francesca
    Fiori, Ginevra
    Bokarewa, Maria
    Riccieri, Valeria
    Becker, Mike
    Avouac, Jerome
    Mueller-Ladner, Ulf
    Distler, Oliver
    Allanore, Yannick
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) : 1217 - 1220
  • [3] Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
    Choy, Ernest
    Groves, Lara
    Sugrue, Daniel
    Hurst, Michael
    Houghton, John
    Venkatachalam, Srinivasan
    Patel, Yusuf I.
    Maxwell, James R.
    Pollock, Kevin G.
    Henning, Sadie
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [4] Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
    Ernest Choy
    Lara Groves
    Daniel Sugrue
    Michael Hurst
    John Houghton
    Srinivasan Venkatachalam
    Yusuf I. Patel
    James R. Maxwell
    Kevin G. Pollock
    Sadie Henning
    BMC Rheumatology, 5
  • [5] OUTCOMES OF PATIENTS TREATED WITH TOCILIZUMAB OR ABATACEPT AS STEROID-SPARING AGENTS WITH GIANT CELL ARTERITIS
    Rossi, Daniela
    Cecchi, Irene
    Rubini, Elena
    Radin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 436 - 436
  • [6] Efficacy, Safety and Continuation Rate of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis : The Comparative Observational Study
    Matsuda, Mayumi
    Asanuma, Yu Funakubo
    Wada, Takuma
    Kouzu, Noritsune
    Sato, Kojiro
    Mimura, Toshihide
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT
    Kuster, S.
    Jordan, S.
    Elhai, M. D.
    Held, U.
    Steigmiller, K.
    Bruni, C.
    Iannone, F.
    Vettori, S.
    Siegert, E.
    Rednic, S.
    Codullo, V.
    Airo, P.
    Braun-Moscovici, Y.
    Hunzelmann, N.
    Salvador, M. J.
    Riccieri, V.
    Gheorghiu, A. M.
    Alegre Sancho, J. J.
    Romanowska-Prochnicka, K.
    Castellvi, I.
    Koetter, I.
    Truchetet, M. E.
    Lopez-Longo, F. J.
    Novikov, P.
    Giollo, A.
    Shirai, Y.
    Belloli, L.
    Zanatta, E.
    Hachulla, E.
    Smith, V.
    Denton, C.
    Ionescu, R.
    Schmeiser, T.
    Distler, J. H. W.
    Gabrielli, A.
    Hoffmann-Vold, A. M.
    Kuwana, M.
    Allanore, Y.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 685 - 686
  • [8] Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
    Kuster, Simon
    Jordan, Suzana
    Elhai, Muriel
    Held, Ulrike
    Steigmiller, Klaus
    Bruni, Cosimo
    Cacciapaglia, Fabio
    Vettori, Serena
    Siegert, Elise
    Rednic, Simona
    Codullo, Veronica
    Airo, Paolo
    Braun-Moscovici, Yolanda
    Hunzelmann, Nicolas
    Salvador, Maria Joao
    Riccieri, Valeria
    Gheorghiu, Ana-Maria
    Sancho, Juan Jose Alegre
    Romanowska-Prochnicka, Katarzyna
    Castellvi, Ivan
    Koetter, Ina
    Truchetet, Marie-Elise
    Lopez-Longo, Fj
    Novikov, Pavel, I
    Giollo, Alessandro
    Shirai, Yuichiro
    Belloli, Laura
    Zanatta, Elisabetta
    Hachulla, Eric
    Smith, Vanessa
    Denton, Chris
    Ionescu, Ruxandra M.
    Schmeiser, Tim
    Distler, Joerg H. W.
    Gabrielli, Armando
    Hoffmann-Vold, Anna-Maria
    Kuwana, Masataka
    Allanore, Yannick
    Distler, Oliver
    RMD OPEN, 2022, 8 (02):
  • [9] CLINICAL AND SEROLOGICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB OR ABATACEPT AS STEROID-SPARING AGENTS
    Rossi, D.
    Cecchi, I.
    Rubini, E.
    Radin, M.
    Sciascia, S.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1477 - 1477
  • [10] Clinical and Serological Outcomes of Patients with Giant Cell Arteritis Treated with Tocilizumab or Abatacept As Steroid-Sparing Agents
    Rossi, Daniela
    Cecchi, Irene
    Rubini, Elena
    Raclin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345